Development of a direct assay for measuring intracellular AZT triphosphate in humans peripheral blood mononuclear cells. 2002

François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
Pharmacology and Immunology Unit, CEA, DSV/DRM, CEA/Saclay, Gif-sur-Yvette, France.

Direct LC/MS/MS methods have recently been developed for measuring triphosphate anabolites of several nucleosidic reverse transcriptase inhibitor (NRTI) in peripheral blood mononuclear cells (PBMCs) from HIV-positive patients. Whereas AZT is one of the most-used NRTIs, no such method has been developed for AZT-TP, its active anabolite, mainly because of the presence of endogenous nucleotides that interfere with such an assay. In this paper, we first describe the development of two enzyme immunoassays (EIA) of AZT-TP in PBMCs: one directly measuring AZT-TP content; the other, measuring the nucleoside AZT after selective extraction of AZT-TP and dephosphorylation. The precision of these two assays was too low to achieve precise determination of AZT-TP in PBMC samples. Direct LC/MS/MS is not specific enough for AZT-TP, since at least two interfering endogenous nucleotides (same m/z ratio and fragment as well as retention time close to that of AZT-TP) are found in the intracellular medium of PBMCs. The off-line combination of immunoaffinity extraction (IAE) and LC/MS/MS proved to be a successful strategy allowing without dephosphorylation appropriate specificity and sensitivity (limit of quantification established as 9.3 fmol/10(6) cells) to determine AZT-TP in PBMCs from 7 mL of blood of HIV-infected patients. Validation of this IAE-LC/MS/MS method demonstrated CV percent for repeatability and intermediate precision lower than 15%. More than 150 samples/week can be analyzed by one analyst, making this method suitable for routine analysis during clinical studies.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013942 Thymine Nucleotides Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. (From Dorland, 28th ed, p1154) Thymidine Phosphates,Nucleotides, Thymine,Phosphates, Thymidine
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D054306 Dideoxynucleotides The phosphate esters of DIDEOXYNUCLEOSIDES. Dideoxynucleotide Triphosphates,ddNTPs,Triphosphates, Dideoxynucleotide
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
January 1994, Antimicrobial agents and chemotherapy,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
July 2009, Journal of neurovirology,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
May 2024, AIDS research and human retroviruses,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
January 2003, Antimicrobial agents and chemotherapy,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
December 2013, Journal of pharmaceutical and biomedical analysis,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
September 1999, Antimicrobial agents and chemotherapy,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
January 2022, Bio-protocol,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
December 2001, Journal of pharmaceutical and biomedical analysis,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
January 2002, Antimicrobial agents and chemotherapy,
François Becher, and Dimitri Schlemmer, and Alain Pruvost, and Marie-Claire Nevers, and Cécile Goujard, and Sylvie Jorajuria, and Catherine Guerreiro, and Thierry Brossette, and Luc Lebeau, and Christophe Créminon, and Jacques Grassi, and Henri Benech
October 1998, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!